IRD: Opus Genetics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 1 sales totaling $2.76M in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-09-30 | Foundation Fighting Blindness Retinal Degeneration Fund / Foundation Fighting Blindness, Inc. | Director | $2.76M |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | Perceptive Advisors LLC | 9.99% | SEC | |
| 2026-08-14 | 13G amendment | Caligan Partners LP | 7.30% | SEC | |
| 2026-08-14 | 13G amendment | BALYASNY ASSET MANAGEMENT L.P. | 6.64% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.